Antigens and epitopes derived from Mycobacterium tuberculosis
US10703784B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2012 |
| Grant date | Jul 7, 2020 |
| Priority date | — |
| Expiry date | Oct 1, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to M. tuberculosis proteins and peptides, and subsequences, portions or modifications thereof and methods and compounds comprising the same for eliciting, stimulating, inducing, promoting, increasing, or enhancing an anti-M. tuberculosis immune response in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.